| Human synonyms | PDCD5 | TFAR19 | GeneID:9141 | ENSG00000105185 | O14737 |
| Mouse ortholog | Pdcd5 | 2200003D22Rik|AA408513|Tfar|Tfar19 | GeneID:56330 | ENSMUSG00000030417 | P56812 |
| Tissue Atlas Coexpression | human GTEx RNA, mouse GNFv3 RNA, mouse protein |
| CCLE cell lines | CRISPR-codependency, RNA-seq coexpression, RNA-microarray, CRISPR-vs-RNA-seq |
| Sequence Alignment (MitoCarta only) | all_BBH, selected_BBH |
| In MitoCarta3.0? | 0 |
| Evidence | MS/MS |
| MitoPathway | |
| Sub-Mito Localization | |
| MS/MS tissues | brainstem, spinalcord |
| MitoCarta2.0 FDR | 0.53 |
| MitoCarta2.0 Training | Tnon_mito |
| TargetP_v1 MTS Confidence | |
| MitoDomain | NA |
| Yeast Homolog | NoMitoHomolog |
| Rickettsia Homolog | NoHomolog |
| GeneAtlas Coexpression N50 | NA |
| PGC Induction | |
| MSMS score | 25-50ambig |
| MSMS intensity | cerebrum:, cerebellum:, brainstem:7.3, spinalcord:7.1, kidney:, liver:, heart:, muscle:, adipose:, sm_intestine:, lg_intestine:, stomach:, placenta:, testis: |
| MSMS unique peps | 5 |
| Curator notes |
| HPA Main Location (2020) | Cytosol (Approved) |
| PFAM domains (2022) | dsDNA_bind |
| CRISPR guides |
| Glu/Gal Death Screen (2016) | not strongly enriched in Gal/Glu dead cells (fdr=1) |
| O2 Screen Summary (2020) | not selectively essential in 1% vs 21% oxygen (fdr=1) |
| 1%O2_vs_21%O2.day15.score (2020) | 0 |
| 21%O2.day15_vs_day0.score (2020) | -1.2 |
| Chemical Genetics Zscore (To 2019) | DMSO:-2.3 (fdr=0.0969); Met:-2.4 (fdr=0.0986); Pier:-2.6 (fdr=0.0471); CAP:-2.5 (fdr=0.0663); |
| TMRM Oligo Zscore (unpublished) | -0.2 |
